BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33493420)

  • 21. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA mortal obligate RNA transcript was downregulated in ovarian carcinoma and inhibits cancer cell proliferation by downregulating miRNA-21.
    Chen X; Wu W; Cao X; Zhao X; Li W; Deng C; Huang Z
    J Cell Biochem; 2019 Jul; 120(7):11949-11954. PubMed ID: 30916806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retracted Article: lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma.
    Hu M; Han Y; Zhang Y; Zhou Y; Ye L
    BMC Med Genet; 2020 Jan; 21(1):2. PubMed ID: 31900116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC01638 lncRNA promotes the proliferation, migration and invasion of prostate carcinoma cells by interacting with Notch1.
    Wu Z; Huang W; Chen Y; Chen B; Liu R; Bai P; Xing J
    Cancer Biomark; 2019; 25(2):161-168. PubMed ID: 31104008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA-ZNF281 Interacts with miR-539 to Promote Hepatocellular Carcinoma Cell Invasion and Migration.
    Zhang Z; Yang L; Yao X; Yang M; Li G
    Cancer Biother Radiopharm; 2020 Mar; 35(2):137-142. PubMed ID: 32073896
    [No Abstract]   [Full Text] [Related]  

  • 26. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.
    Mo M; Liu S; Ma X; Tan C; Wei L; Sheng Y; Song Y; Zeng X; Huang D; Qiu X
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2027-2038. PubMed ID: 31243545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA HAND2‑AS1 mediates the downregulation of ROCK2 in hepatocellular carcinoma and inhibits cancer cell proliferation, migration and invasion.
    Jiang L; He Y; Shen G; Ni J; Xia Z; Liu H; Cao Y; Li X
    Mol Med Rep; 2020 Mar; 21(3):1304-1309. PubMed ID: 31922232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
    Liu W
    Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA TSPEAR-AS1 predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma and promotes metastasis via miR-1915-5p.
    Zhang Y; Wang F; Wang Y
    Virus Res; 2022 Jul; 315():198788. PubMed ID: 35477008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
    Chen K; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA PAPAS promotes hepatocellular carcinoma by interacting with miR-188-5p.
    Ma J; Qin C; Yuan Z; Liu S
    J Cell Biochem; 2019 Aug; 120(8):13494-13500. PubMed ID: 30920025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells.
    Zhong Y; Li Y; Song T; Zhang D
    Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Dig Dis Sci; 2013 Apr; 58(4):1016-25. PubMed ID: 23053901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.